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Abstract
We examined an obese 58-year-old patient with a bilater-
al posterior hypothalamic lesion of unknown etiology. A
24-hour polysomnography revealed a markedly in-
creased total sleep time (17.6 h). During daytime, only 3
continuous wake phases occurred. REM periods oc-
curred only between 5 p.m. and 6 a.m. We conclude from
our results that, similar to the results from animal experi-
ments, the posterior hypothalamus in humans plays a
critical role in the maintenance of wakefulness.
Copyright © 2003 S. Karger AG, Basel
Objectives
It is postulated from animal studies that the posterior
hypothalamus is important for maintaining wakefulness
[1], whereas the anterior hypothalamus promotes sleep [2]
and regulates the sleep-wake cycle [3]. To elucidate the
role of the posterior hypothalamus in circadian rhythm
with regard to sleep in humans, we examined a patient
with a bilateral posterior hypothalamic lesion of unknown
etiology using polysomnography (PSG). This, to the best
of our knowledge, has not been done before.
Case Report
Patient History
On first admission this obese 58-year-old female patient (BMI:
46.5 kg/m2) reported a 2-month history of circadian temperature
peaks in the evening (up to 39.6 °C), progressive daytime sleepiness,
apathy, irritability and hyperphagia.
Neurological, physical and psychiatric examinations were nor-
mal. Blood pressure was 180/110 mm Hg. Ophthalmologic explora-
tion revealed concentric visual field loss of 30° in both eyes. Cranial
MRI showed bilateral, Gadolinium-enhanced lesions in the posterior
hypothalamus. Thoracic and abdominal computed tomographies,
echocardiography, microbiological blood, urine and stool cultures
were normal.
Five months after the first admission the clinical symptoms were
still slowly progressive. Due to the homogeneous form and symmetry
of the hypothalamic lesion, sarcoidosis was suspected and the patient
was treated with methylprednisolone (initially 100 mg/day, tapering
down to a maintenance dose of 2 mg every other day for 7 months)
and azathioprine (100 mg/day). Azathioprine had to be stopped after
3 months because of a marked increase of liver enzymes [alkaline
phosphatase (AP): 265 U/l; Á-glutamyl transpeptidase: 650 U/l; glu-
tamic pyruvic transaminase: 64 U/l; glutamic oxalacetic transami-
nase (GOT): 47 U/l; lactate dehydrogenase: 382 U/l].
Five months after the beginning of immunosuppressive therapy,
hypersomnia and weight gain were still marked. Temperature peaks
still occurred mostly in the evening. Visual fields improved to 50° of
concentric impairment.
One year after her first admission she died at home of unknown
causes after having gained about 35 kg of weight. She had spent the
last few months sleeping in bed most of the time. Her husband did
not permit post-mortem pathological examination.
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Fig. 1. Cranial MRI (sagittal T1-weighted image) showing the con-
trast-enhanced lesion in the posterior hypothalamus on first admis-
sion (arrow).
Cranial MRI
Serial MRI, including T1-, T2- and proton-weighted images, with
and without Gadolinium, were performed 7 times. The initial MRI
showed a bilateral, Gadolinium-enhanced lesion in the posterior
hypothalamic nuclei, and tuberally and centrally (fig. 1). Lateral and
anterior hypothalamic structures were not affected. Five months
after the first admission but before the beginning of immunosuppres-
sive therapy, the lesion had discretely increased in size but did not
invade hypothalamic structures near or anterior to the optic chiasm.
Five months after the beginning of immunosuppressive therapy, cra-
nial MRI showed a reduction of the contrast enhancement and size of
the hypothalamic lesions as well as a widening of the third ventricle,
most likely due to atrophy.
Sleep Studies
A digital system (Brainlab, Schwarzer, Munich, Germany) was
used to record the PSG. The study began around 4 p.m. and ended
around 4 p.m. the next day; electroencephalogram, electro-oculo-
gram, electromyogram, electrocardiogram and breathing parameters
were recorded and scored, as recently published in detail [4].
Sleep Analysis
A 24-hour PSG was performed 5 months after the start of immu-
nosuppressive therapy. Total sleep time (TST) was 17.6 h, 7.4% of
which was stage I, 34.1% stage II, 21% stage III, 8.5% stage IV and
19.9% REM stage. There were only three continuous wake phases of
more than 30 min, all during the daytime and lasting less than 1 h.
REM sleep did not occur between 7 a.m. and 5 p.m. There was no
significant increase of periodic limb movements or apneas/hypo-
pneas during sleep.
Results
Blood analyses were performed on first admission and
several times during and after 5 months of immunosup-
pressive therapy.
Endocrinology
Thyrotropin-releasing factor and growth hormone re-
leasing factor tests were within the normal range in the
morning. The cortisol profile (8 a.m., 2 p.m., 7 p.m., 11
p.m.) was also normal. Morning analyses of thyroid hor-
mones, estradiol, testosterone, luteotropic hormone (LH),
follicle-stimulating hormone (FSH), human chorionic go-
nadotropin, and somatomedin C also revealed normal
results. Increased morning prolactin (table 1) indicated
dysfunction of the tuberoinfundibular hypothalamic re-
gion [5]. Possibly due to the elevated prolactin level, LH
and FSH secretion could not be stimulated with luteo-
tropic hormone-releasing factor in the morning.
Five months after the beginning of immunosuppres-
sive therapy, prolactin was still elevated (table 1) and the
other endocrinological parameters did not change.
Serological Parameters
For pathological values see table 1. Values for angio-
tensin-converting enzyme, C-reactive protein, electro-
lytes, HbA1c, uric acid, triglycerides, bilirubin, pseudo-
cholinesterase, lipase, creatine kinase, Quick, PTT, AP,
B2 microglobulin, A2 haptoglobin, ·-fetoprotein, GOT,
serum and urinary osmolalities, and serum electrophore-
sis were normal at different times during the day. Serolog-
ical analyses for cytomegalovirus (including clonab® test),
Lyme, syphilis, Herpes simplex, hepatitis A, B, C, and
Epstein-Barr virus were negative.
Blood Cell Count
Pathological values are listed in table 1; the other val-
ues were within normal range.
CSF
CSF analyses revealed a lymphocytic inflammatory
process on first admission, which was absent 5 months
after the beginning of the immunosuppressive therapy (ta-
ble 1).
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Table 1. Pathological laboratory tests
On first admission 5 Months OT
Prolactin, ng/ml 81.8 83.4
Glucose, mg/dl 169 normal
Á-GT, U/l 60 normal
GPT, U/l 35 normal
MCH, pg 34.5 normal
Erythrocytes 4.13 T/l normal




OCBs positive in CSF and serum positive in CSF only
CSF ACE negative negative
OT = After onset of immunosuppressive therapy; ACE = angiotensin-converting enzyme;
CSF = cerebrospinal fluid; Á-GT = Á-glutamyl transpeptidase; GPT = glutamic pyruvic trans-
aminase; MCH = mean corpuscular hemoglobin; OCBs = oligoclonal bands.
Neuropsychological Examination
Neuropsychological examination was performed on
first admission and 5 months after the beginning of
immunosuppressive therapy. The patient showed consis-
tent memory deficits as regards verbal learning as well as
retrograde amnesia for the last 10 years. Her memory
span for words was initially highly reduced but returned
to normal 5 months after beginning immunosuppressive
therapy. Orientation as to time and place was limited, and
there was a pronounced attention deficit with cognitive
slowing. In addition, an impairment of executive func-
tions was seen. The patient’s awareness of her disabilities
was clearly reduced.
Temperature
Temperature was usually normal in the morning hours
(around 37°C) and rose in the late afternoon or evening,
reaching peaks up to 39.6°C.
Conclusions
Hypersomnia
This case study provides the first reported full-day
polysomnographic evaluation of a human with bilateral
posterior hypothalamic lesion. The main finding in our
patient was severe hypersomnia with preserved sleep-
wake cycle.
Bilateral anterior hypothalamic lesion, however, has
been associated with disrupted temporal patterns of the
sleep-wake cycle in which there were periods of daytime
hypersomnolence and increased body temperature [6].
Markedly increased TST in our patient reflected hyper-
somnia. The circadian sleep-wake cycle was preserved:
only short awakenings occurred during the night; all REM
phases were restricted to the night period, and the longest
periods of wakefulness occurred during daytime. Our
finding of hypersomnia with preserved sleep-wake cycle
in bilateral posterior hypothalamic lesion in the human is
in keeping with results from animal studies: the supra-
chiasmatic nucleus in the anterior hypothalamus of the
rat is considered the main pacemaker for the sleep-wake
cycle [3], whereas the posterior hypothalamus of the rat is
supposed to function as a waking center [1, 2].
Hyperthermia
Hyperthermia is a common and typical feature of
lesions of the tuberoinfundibular region of the hypothala-
mus [7], which was also lesioned in our patient. Our
patient still showed some circadian variability of body
temperature, which suggests an intact circadian pacemak-
er for body temperature in the anterior hypothalamus.
Schwartz et al. [8] demonstrated a change in daily temper-
ature rhythm without increase in mean daily temperature
in a patient with an anterior hypothalamic lesion and
hypothesized that this was due to the disturbed function
of this region.
Hyperphagia
Our results are supported by animal experiments
showing that hyperphagia is associated with bilateral pos-
terior hypothalamic lesions in rats [9].
172 Eur Neurol 2003;49:169–172 Eisensehr/Noachtar/von Schlippenbach/
Uttner/Kleine/Seelos/Helmchen
Neuropsychology
Memory deficits as seen in our patient may be associat-
ed with the degeneration of the dorsal medial hypotha-
lamic nucleus [10], but they were also seen after lesions of
the anterior hypothalamus [6]. A disruption of the lateral
amygdalofugal pathways projecting to the region of ven-
tral medial nucleus was discussed as a possible explana-
tion.
Conclusion
Pathological findings in our patient were caused most
probably by the location of the CNS lesion bilaterally in
the posterior hypothalamus. Systemic influences of sar-
coidosis have not been suggested to lead to hypersomnia,
hyperphagia, hyperthermia, and memory deficits. More-
over, these symptoms already existed before the initiation
of immunosuppressive therapy, conclusively excluding
the possibility that immunosuppressive therapy would be
the cause of the complaints.
Our case supports the animal experiment-based hy-
pothesis that the posterior hypothalamus works as a cen-
ter for maintenance of wakefulness. Homologous to the
rat hypothalamus, the posterior hypothalamus in humans
does not seem to be necessary for a functioning sleep-
wake cycle. Our results further support the hypothesis of
an important role of the human posterior hypothalamus
in regulating food intake, keeping the body temperature
within the normal range and in maintaining intact memo-
ry as well as executive functions.
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